Calendar Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
21.03 USD +0.62% Intraday chart for Cartesian Therapeutics, Inc. +17.42% +1.68%

Chart calendar Cartesian Therapeutics, Inc.

3cff70cab9cfbf131a69e54214eed.fPIy8_nz3JG820bfjtk4bbl6ccfU86jIG1DySGb8Qns.DZBArM27tcDluDacvu1yHIxLE_ezysCMeRmaEgDOJi81o2GDvL2d3sWWDw~1ddb1407c94e36734cea4df637eb31c6

Upcoming events on Cartesian Therapeutics, Inc.

10/05/2024 11:15 pm American Society of Gene & Cell Therapy Meeting - Abstract Number: 241

Past events on Cartesian Therapeutics, Inc.

10/04/2024 12:30 am Needham Healthcare Conference
27/03/2024 06:30 pm Extraordinary Shareholders Meeting
26/03/2024 08:30 pm H.C. Wainwright Cell Therapy Virtual Conference
13/03/2024 06:10 pm Leerink Partners Global Biopharma Conference
07/03/2024 05:30 pm Q4 2023 Earnings Release
17/08/2023 06:00 pm Q2 2023 Earnings Call
17/08/2023 04:30 pm Q2 2023 Earnings Release
16/06/2023 07:30 pm Annual General Meeting
31/05/2023 European Alliance of Associations for Rheumatology European Congress
04/05/2023 06:00 pm Q1 2023 Earnings Call
04/05/2023 05:00 pm Q1 2023 Earnings Release
21/03/2023 06:00 pm DISSOLVE I & II SEL-212 Phase 3 Trail Results Call
02/03/2023 07:00 pm Q4 2022 Earnings Call
02/03/2023 Q4 2022 Earnings Release
14/02/2023 06:30 pm SVB Securities Global Biopharma Conference
15/11/2022 12:05 am Immunology & Neurology Day
03/11/2022 06:00 pm Q3 2022 Earnings Call
03/11/2022 05:30 pm Q3 2022 Earnings Release
11/10/2022 10:00 pm European Society of Gene and Cell Therapy Conference - OR06
01/10/2022 12:00 am Jefferies Cell and Genetic Medicine Summit

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


26,0
10,6
145.32%

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-86,4
-14,3
-506.39%

-40,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,46


-239
-13,7
-1645.21%

-32,2

Net income
Million USD
Released
Forecast
Spread
-6,46


-220
-13,7
-1506.3%

-37,8

EPS
USD
Released
Forecast
Spread
0,00


-49,8
-0,60
-8200.01%

-1,62

Announcement Date23/01/2407/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread

2,50


0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread

-6,00


-8,63


-9,00


-10,4


-12,3


-14,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread

-5,91


-6,29


-7,62


-8,46


-9,81


-10,9

Net income
Million USD
Released
Forecast
Spread

-5,91


-8,14


-8,31


-9,73


-11,7


-13,5

EPS
USD
Released
Forecast
Spread

-0,30


-0,35


-0,36


-0,42


-0,50


-0,57

Announcement Date------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RNAC Stock
  4. Calendar Cartesian Therapeutics, Inc.